Self-Acupressure Eases Fatigue, Sleep Problems and Depression in Breast Cancer Survivors

Breast cancer survivors often find that the hardest part of the disease begins after treatment ends. While survival rates for early-stage breast cancer now exceed 90 percent in high-income countries, many women continue to battle a stubborn trio of symptoms: crushing fatigue, disturbed sleep and depression. These three symptoms frequently co-occur, feed into one another and are increasingly studied not as isolated complaints but as a single interconnected phenomenon known as the fatigue-sleep disturbance-depression symptom cluster. A newly published phase III randomised controlled trial, reported in the journal Supportive Care in Cancer, offers striking evidence that a simple, low-cost technique rooted in traditional Chinese medicine—self-acupressure—can significantly reduce this entire symptom cluster and improve quality of life, with effects that persist for months after the practice begins.

The trial, led by Mengyuan Li and colleagues at the University of Southern Queensland and partner institutions in Australia and China, enrolled 108 women who had completed chemotherapy for early-stage breast cancer between one month and three years earlier. Each participant reported at least moderate levels of fatigue, sleep disturbance and depression, scoring four or higher on a standard 0-to-10 rating scale. The women were randomly allocated in equal numbers to one of three groups: a true self-acupressure group, a sham self-acupressure group, or a usual care group. Ninety-three participants completed the study, with 31 in each arm, and the retention rate of 86 percent was notably strong for a trial of this length and population.

The intervention itself was elegantly simple. Women in the true acupressure group were trained in a 20-minute face-to-face session to apply firm pressure to eleven acupoints, seven of them bilateral, chosen for their traditional and emerging scientific relevance to fatigue, sleep and mood. These included well-known points such as Zusanli (ST36) on the lower leg, Neiguan (PC6) on the forearm, Shenmen (HT7) on the wrist, and Yintang (EX-HN3) between the eyebrows. Each point was stimulated for two minutes, adding up to a daily 36-minute practice continued for seven weeks. Participants in the sham group followed an identical regimen but pressed eleven non-acupoints located one to three centimetres away from the real points and deliberately off the classical meridians. Because both groups performed an active, plausible technique, neither the participants nor the self-rated outcome assessments could distinguish true from sham treatment, providing a rigorous test of whether acupressure’s benefits depend on stimulating specific points or simply on the ritual of self-care.

The results were unambiguous. Using a sophisticated statistical approach—generalised estimating equations with covariate selection guided by penalised regression—the researchers found significant group-by-time interactions for every clinical outcome. The true self-acupressure group showed substantially greater reductions in the composite symptom cluster score than both comparison groups, not only at the end of the seven-week intervention but also at the twelve-week follow-up, with large standardised effect sizes reaching as high as 2.33 against usual care. Crucially, the benefits were sustained: the advantage over the sham group actually grew over time, suggesting that continued practice deepened the therapeutic effect rather than fading like a placebo response.

At the level of individual symptoms, the pattern was equally compelling. Sleep disturbance, measured with the Pittsburgh Sleep Quality Index, and depression, measured with the Hospital Anxiety and Depression Scale, both improved significantly more in the true acupressure group than in either comparison group at both assessment points. Fatigue, measured with the Brief Fatigue Inventory, showed a large advantage over usual care throughout, while the difference between true and sham acupressure reached statistical significance only at the twelve-week follow-up. Quality of life, assessed with the Functional Assessment of Cancer Therapy-Breast instrument, rose markedly in the true acupressure group, with the gap over the sham group widening from a non-significant trend at week seven to a highly significant difference by week nineteen.

One of the most scientifically interesting findings concerns the sham group itself. Women who pressed non-acupoints also fared significantly better than those receiving usual care, with moderate effect sizes. The authors attribute this to placebo and psychosocial mechanisms: the strong desire for symptom relief, positive expectations, and the act of actively engaging in a daily self-care ritual can all modulate symptom perception through genuine psychological and physiological pathways. This does not diminish the value of the true intervention—whose effects were consistently larger and more durable—but it does highlight how much of symptom management in cancer survivorship may be harnessed through expectation and self-efficacy. The trial’s design, following a sham-controlled structure refined through an earlier phase II pilot study, allowed the researchers to separate these non-specific effects from the specific benefits of stimulating authentic acupoints.

Why might pressing specific points on the body influence fatigue, sleep and mood at all? The prevailing biological explanation for this symptom cluster is cytokine-induced sickness behaviour: cancer treatments trigger persistent low-grade inflammation, and pro-inflammatory signalling molecules act on the brain to produce the lethargy, sleep disruption and low mood that survivors describe. Non-pharmacological interventions such as exercise, acupuncture and acupressure have been shown in prior research to reduce circulating pro-inflammatory cytokines, offering a plausible mechanistic bridge. The trial’s authors acknowledge, however, that they did not directly measure cytokines in this study, leaving the precise biological pathway an open question for future work.

Safety and cost are where the findings become genuinely striking for clinical practice. Not a single adverse event was reported across the entire trial, a stark contrast to acupuncture, which carries small risks of infection and bruising due to its invasive nature, and to pharmacological approaches, which raise concerns about drug interactions in patients already on complex regimens. The economic picture was similarly favourable: during the trial, only one participant in the true acupressure group and one in the usual care group used healthcare resources for symptom relief, with total costs of 931.06 and 2,247.44 yuan respectively, while the only direct intervention cost was a one-off 2,879 yuan for producing instructional videos. The researchers caution that these numbers are too sparse for a formal cost-effectiveness analysis, but the direction of the data is hard to ignore.

The trial was not without limitations. All outcomes relied on self-reported questionnaires, which, although well-validated, are inherently subjective; the authors recommend that future studies incorporate objective measures such as actigraphy or inflammatory biomarkers. The composite cluster score assumed equal weighting of the three symptoms, and adherence to the full 49-day practice schedule was challenging, with only about 28 percent of the true acupressure group completing every day. Yet even partial adherence produced large effects, and the researchers suggest that real-world implementation could allow individualised adjustments to session length based on each woman’s energy and symptom burden.

The implications reach well beyond breast cancer. With more than 53 million people worldwide now living five or more years past a cancer diagnosis, accessible, self-managed strategies for the lingering burden of survivorship are urgently needed. Cognitive behavioural therapy demands multiple sessions with trained therapists; exercise programmes can be exhausting for women already depleted by fatigue. Self-acupressure, by contrast, requires only a short training, can be practised anywhere at any time, and costs almost nothing once learned. The authors argue that the intervention could be readily integrated into routine survivorship care and primary healthcare settings, particularly where professional resources are scarce. As the first fully powered phase III trial to demonstrate sustained, cluster-level benefits of self-acupressure in breast cancer survivors, the study transforms an ancient technique into a modern, evidence-based prescription—one that patients can literally hold in their own hands.

Subject of Research: Self-acupressure for managing the fatigue-sleep disturbance-depression symptom cluster in breast cancer survivors

Article Title: Effects of self-acupressure on the fatigue-sleep disturbance-depression symptom cluster in breast cancer survivors: a phase III randomised controlled trial

Article References: Li, M., Kwok, W. H., Wang, T., Deng, R., Wang, H., Yao, L., Deravin, L., Yang, L., Tian, X., & Tan, J.-Y. B. (2026). Effects of self-acupressure on the fatigue-sleep disturbance-depression symptom cluster in breast cancer survivors: a phase III randomised controlled trial. Supportive Care in Cancer, 34(10), Article 981. https://doi.org/10.1007/s00520-026-11155-2

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11155-2

Keywords: self-acupressure, breast cancer survivors, symptom cluster, fatigue, sleep disturbance, depression, randomised controlled trial, quality of life, traditional Chinese medicine, cancer survivorship, non-pharmacological intervention, placebo effect